EFTA
Search
Search
Entities
About
Settings
/
to search
Search
Search syntax help
Dataset
Set 1
Set 2
Set 3
Set 4
Set 5
Set 6
Set 7
Set 8
Set 9
Set 10
Set 11
Set 12
Sort
Relevance
Most pages
Most words
Dataset
Newest
Oldest
Status
All
Extracted
Failed
DOJ Status
All
Removed
Available
Date Range
Undated only
–
Page Count
–
Saved Searches
+
2 results for “
"EU Pharma"
”
Export
EFTA01432866
Set 10
2018-07-01
106p
17,893w
380p 5377p Source: Deutsche Bank Shares are now very cheap on lyr PE vs.
EU
Pharma
0.4 0.8 1.2 1.6 Jan 10 Source: Deutsche Bank 18 Dec 11 Shire ...
EU
Pharma
Rel to
EU
Pharma
4yr Ave +1 s.d. -1 s.d. Dec 13 Dec 15 Dec 17 PE rel to sector (x), lY fwd EFTA01432897 Energy, Materials and Industrials
Keyboard Shortcuts
/
Focus search
Esc
Blur input
O
Open PDF
←
→
Paginate
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01432866.pdf
EFTA01385517
Set 10
1p
362w
Lanadelumab (launch expected in 2H18). Shares are now very cheap on lyr PE vs.
EU
Pharma
• Shares are far too cheap at just 8x 19E PE and 9x EV/EBITDA. Shire ... Shire 1yr fwd PE rel to
EU
Pharma
the cheapest stock in our coverage after '17 underperformance, driven by PE rel to sector (x). 1V fwd 16 Rel to
EU
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01385517.pdf
Corpus: 1990-03-17 – 2025-12-01
←
July 2018
→
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Undated
(150,429)
None
Light
Medium
Heavy
Results by Dataset
2 total
Set 10
2